Objective: The objective this study is to evaluate the potential of magnetic-lazer therapy as a supportive treatment of peri-implantitis.
Materials and Methods: The 34 patients suffering from Peri-Implantitis were selected for this study. The patients randomly divided into two groups; 18 patients first group received surgical conventional treatment,16 patients second group received surgical conventional treatment and magnetic-lazer application. A total of 46 implants were treated with moderate peri-implantitis. Diagnostic parameters used to evaluate peri-implantitis include clinical indicators, Probing Pocket Depth (PPD), Bleeding On Probing (BOP), Marginal Bone Level (MBL) suppuration, mobility. Clinical and radiographical parameters were recorded before treatment (baseline) and at 3, 6 and 12, 36 months after therapy.
Results: Reduction PPD and BOP was observed in comparison with basic clinical measurements. The mean BOP in 34 patients before treatment of peri-implantitis was 2.5 ± 0.31, after treatment, the first group of patients had mean 0.6 ± 0.1, the second group had mean 0.4 ± 0.12. The mean PPD in patients before treatment of peri-implantitis was 5,2±0,24, after treatment, the first group of patients had mean 3,9±0,28, the second group had mean 3,2±0,17.
The mean MBL concomitant bone level gain averaged was 1, 54 mm in first group and 2.35 mm in second group. Stable clinical measurements PPD and BOP were demonstrated during the following 1,3 years.
Conclusion: Surgical regenerative treatment combined with magnetic-laser supportive therapy reliable method for treatment peri-implantitis and may be considered an adjunct to the conventional surgical treatments of peri-implantitis
